In contrast, EIPA or NAV2729 treatment slowed tumor growth on the left side (EV receiver) compared to Ctrl (Fig. 7F), confirming that Arf6-driven macropinocytosis promotes SFR. The gene discussed is ARF6; the disease is neoplasm.